Hajo Kries
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hajo Kries has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
Aleksa Stanišić
Biosynthetic Design of Natural Products, Leibniz Institute for Natural Product Research and Infection Biology – Hans-Knöll-Institute (HKI), Beutenbergstraße 11a, 07745 Jena, Germany
10 shared publicationsPhilipp Stephan
Junior Research Group Biosynthetic Design of Natural Products Leibniz Institute for Natural Product Research and Infection Biology (HKI) Beutenbergstr. 11a 07745 Jena Germany
10 shared publications- Sarah Ellen O'COnnor
Department of Natural Product Biosynthesis, Max Planck Institute for Chemical Ecology
9 shared publications - Christian Hertweck
Department of Biomolecular Chemistry, Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute (Leibniz-HKI), Jena, Germany
6 shared publications - Donald Hilvert
Laboratory of Organic Chemistry, ETH Zurich, Zurich, Switzerland
6 shared publications Donald Hilvert
Department of Chemistry and Applied Biosciences, Laboratory of Organic Chemistry, Swiss Federal Institute of Technology Zurich (ETH Zurich), 8093, Zurich, Switzerland
4 shared publications
Latest Publications
- Open Access
- 9 September 2026
- Published by Wiley in Angewandte Chemie
- Vol. 138 (43) , e9880949
Adenylation Domain Engineering Enables Biosynthesis of an Improved Polymyxin Antibiotic
Polymyxins are potent nonribosomal peptide antibiotics, yet their clinical use is limited by a narrow therapeutic window and nephro‐/neurotoxicity. Conventional efforts to improve these agents rely on the incorporation of nonnatural building blocks that cannot be accessed biosynthetically and therefore must be introduced by total synthesis. Here we report a biosynthetic route to a next‐generation polymyxin that circumvents this limitation. By engineering the substrate‐binding pocket of a nonribosomal adenylation (A‐)domain, we created a mutationally expanded pocket that selectively activates the fatty amino acid l ‐2‐aminodecanoic acid ( l ‐Ada). Incorporation of this engineered A‐domain into the native polymyxin biosynthesis enabled production of Ada‐polymyxin with high potential for lowered toxicity directly in Paenibacillus polymyxa fermentation. This work demonstrates that rational redesign of nonribosomal A‐domains can redirect natural product biosynthesis toward chemically diverse, therapeutically superior antibiotics, opening new avenues for combating drug‐resistant bacteria.
- 9 September 2026
- Published by Wiley in Angewandte Chemie
- Vol. 138 (43) , e9880949
Open AccessAdenylation Domain Engineering Enables Biosynthesis of an Improved Polymyxin Antibiotic
Polymyxins are potent nonribosomal peptide antibiotics, yet their clinical use is limited by a narrow therapeutic window and nephro‐/neurotoxicity. Conventional efforts to improve these agents rely on the incorporation of nonnatural building blocks that cannot be accessed biosynthetically and therefore must be introduced by total synthesis. Here we report a biosynthetic route to a next‐generation polymyxin that circumvents this limitation. By engineering the substrate‐binding pocket of a nonribosomal adenylation (A‐)domain, we created a mutationally expanded pocket that selectively activates the fatty amino acid l ‐2‐aminodecanoic acid ( l ‐Ada). Incorporation of this engineered A‐domain into the native polymyxin biosynthesis enabled production of Ada‐polymyxin with high potential for lowered toxicity directly in Paenibacillus polymyxa fermentation. This work demonstrates that rational redesign of nonribosomal A‐domains can redirect natural product biosynthesis toward chemically diverse, therapeutically superior antibiotics, opening new avenues for combating drug‐resistant bacteria.
- Open Access
- 9 September 2026
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (43)
Adenylation Domain Engineering Enables Biosynthesis of an Improved Polymyxin Antibiotic
Polymyxins are potent nonribosomal peptide antibiotics, yet their clinical use is limited by a narrow therapeutic window and nephro‐/neurotoxicity. Conventional efforts to improve these agents rely on the incorporation of nonnatural building blocks that cannot be accessed biosynthetically and therefore must be introduced by total synthesis. Here we report a biosynthetic route to a next‐generation polymyxin that circumvents this limitation. By engineering the substrate‐binding pocket of a nonribosomal adenylation (A‐)domain, we created a mutationally expanded pocket that selectively activates the fatty amino acid l ‐2‐aminodecanoic acid ( l ‐Ada). Incorporation of this engineered A‐domain into the native polymyxin biosynthesis enabled production of Ada‐polymyxin with high potential for lowered toxicity directly in Paenibacillus polymyxa fermentation. This work demonstrates that rational redesign of nonribosomal A‐domains can redirect natural product biosynthesis toward chemically diverse, therapeutically superior antibiotics, opening new avenues for combating drug‐resistant bacteria.
- 9 September 2026
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (43)
Open AccessAdenylation Domain Engineering Enables Biosynthesis of an Improved Polymyxin Antibiotic
Polymyxins are potent nonribosomal peptide antibiotics, yet their clinical use is limited by a narrow therapeutic window and nephro‐/neurotoxicity. Conventional efforts to improve these agents rely on the incorporation of nonnatural building blocks that cannot be accessed biosynthetically and therefore must be introduced by total synthesis. Here we report a biosynthetic route to a next‐generation polymyxin that circumvents this limitation. By engineering the substrate‐binding pocket of a nonribosomal adenylation (A‐)domain, we created a mutationally expanded pocket that selectively activates the fatty amino acid l ‐2‐aminodecanoic acid ( l ‐Ada). Incorporation of this engineered A‐domain into the native polymyxin biosynthesis enabled production of Ada‐polymyxin with high potential for lowered toxicity directly in Paenibacillus polymyxa fermentation. This work demonstrates that rational redesign of nonribosomal A‐domains can redirect natural product biosynthesis toward chemically diverse, therapeutically superior antibiotics, opening new avenues for combating drug‐resistant bacteria.
- Open Access
- 26 February 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (16) , 8168-8181
Mapping the nonribosomal specificity code through promiscuity-guided A-domain engineering
From specialist to generalist and back: probing active-site mutations defines a roadmap for redesigning substrate specificity of adenylation domains from nonribsomal peptide synthesis.
- 26 February 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (16) , 8168-8181
Open AccessMapping the nonribosomal specificity code through promiscuity-guided A-domain engineering
From specialist to generalist and back: probing active-site mutations defines a roadmap for redesigning substrate specificity of adenylation domains from nonribsomal peptide synthesis.
- Open Access
- 23 February 2024
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 19 (3) , 599-606
Controlling Substrate- and Stereospecificity of Condensation Domains in Nonribosomal Peptide Synthetases
Nonribosomal peptide synthetases (NRPSs) are sophisticated molecular machines that biosynthesize peptide drugs. In attempts to generate new bioactive compounds, some parts of NRPSs have been successfully manipulated, but especially the influence of condensation (C-)domains on substrate specificity remains enigmatic and poorly controlled. To understand the influence of C-domains on substrate preference, we extensively evaluated the peptide formation of C-domain mutants in a bimodular NRPS system. Thus, we identified three key mutations that govern the preference for stereoconfiguration and side-chain identity. These mutations show similar effects in three different C-domains (GrsB1, TycB1, and SrfAC) when di- or pentapeptides are synthesized in vitro or in vivo. Strikingly, mutation E386L allows the stereopreference to be switched from d- to l-configured donor substrates. Our findings provide valuable insights into how cryptic specificity filters in C-domains can be re-engineered to clear roadblocks for NRPS engineering and enable the production of novel bioactive compounds.
- 23 February 2024
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 19 (3) , 599-606
Open AccessControlling Substrate- and Stereospecificity of Condensation Domains in Nonribosomal Peptide Synthetases
Nonribosomal peptide synthetases (NRPSs) are sophisticated molecular machines that biosynthesize peptide drugs. In attempts to generate new bioactive compounds, some parts of NRPSs have been successfully manipulated, but especially the influence of condensation (C-)domains on substrate specificity remains enigmatic and poorly controlled. To understand the influence of C-domains on substrate preference, we extensively evaluated the peptide formation of C-domain mutants in a bimodular NRPS system. Thus, we identified three key mutations that govern the preference for stereoconfiguration and side-chain identity. These mutations show similar effects in three different C-domains (GrsB1, TycB1, and SrfAC) when di- or pentapeptides are synthesized in vitro or in vivo. Strikingly, mutation E386L allows the stereopreference to be switched from d- to l-configured donor substrates. Our findings provide valuable insights into how cryptic specificity filters in C-domains can be re-engineered to clear roadblocks for NRPS engineering and enable the production of novel bioactive compounds.
- 15 February 2024
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 19 (3) , 660-668
Analysis of the Valgamicin Biosynthetic Pathway Reveals a General Mechanism for Cyclopropanol Formation across Diverse Natural Product Scaffolds
Cyclopropanol rings are highly reactive and may function as molecular "warheads" that affect natural product bioactivity. Yet, knowledge on their biosynthesis is limited. Using gene cluster analyses, isotope labeling, and in vitro enzyme assays, we shed first light on the biosynthesis of the cyclopropanol-substituted amino acid cleonine, a residue in the antimicrobial depsipeptide valgamicin C and the cytotoxic glycopeptide cleomycin A2. We decipher the biosynthetic origin of valgamicin C and show that the cleonine cyclopropanol ring is derived from dimethylsulfoniopropionate (DMSP). Furthermore, we demonstrate that part of the biosynthesis is analogous to the formation of malleicyprol polyketides in pathogenic bacteria. By genome mining and metabolic profiling, we identify the potential to produce cyclopropanol rings in other bacterial species. Our results reveal a general mechanism for cyclopropyl alcohol biosynthesis across diverse natural products that may be harnessed for bioengineering and drug discovery.
- 15 February 2024
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 19 (3) , 660-668
Analysis of the Valgamicin Biosynthetic Pathway Reveals a General Mechanism for Cyclopropanol Formation across Diverse Natural Product Scaffolds
Cyclopropanol rings are highly reactive and may function as molecular "warheads" that affect natural product bioactivity. Yet, knowledge on their biosynthesis is limited. Using gene cluster analyses, isotope labeling, and in vitro enzyme assays, we shed first light on the biosynthesis of the cyclopropanol-substituted amino acid cleonine, a residue in the antimicrobial depsipeptide valgamicin C and the cytotoxic glycopeptide cleomycin A2. We decipher the biosynthetic origin of valgamicin C and show that the cleonine cyclopropanol ring is derived from dimethylsulfoniopropionate (DMSP). Furthermore, we demonstrate that part of the biosynthesis is analogous to the formation of malleicyprol polyketides in pathogenic bacteria. By genome mining and metabolic profiling, we identify the potential to produce cyclopropanol rings in other bacterial species. Our results reveal a general mechanism for cyclopropyl alcohol biosynthesis across diverse natural products that may be harnessed for bioengineering and drug discovery.
- Open Access
- 25 October 2023
- Published by Wiley in Angewandte Chemie
- Vol. 136 (4)
Novel Biocatalysts from Specialized Metabolism
Enzymes are increasingly recognized as valuable (bio)catalysts that complement existing synthetic methods. However, the range of biotransformations used in the laboratory is limited. Here we give an overview on the biosynthesis‐inspired discovery of novel biocatalysts that address various synthetic challenges. Prominent examples from this dynamic field highlight remarkable enzymes for protecting‐group‐free amide formation and modification, control of pericyclic reactions, stereoselective hetero‐ and polycyclizations, atroposelective aryl couplings, site‐selective C−H activations, introduction of ring strain, and N−N bond formation. We also explore unusual functions of cytochrome P450 monooxygenases, radical SAM‐dependent enzymes, flavoproteins, and enzymes recruited from primary metabolism, which offer opportunities for synthetic biology, enzyme engineering, directed evolution, and catalyst design.
- 25 October 2023
- Published by Wiley in Angewandte Chemie
- Vol. 136 (4)
Open AccessNovel Biocatalysts from Specialized Metabolism
Enzymes are increasingly recognized as valuable (bio)catalysts that complement existing synthetic methods. However, the range of biotransformations used in the laboratory is limited. Here we give an overview on the biosynthesis‐inspired discovery of novel biocatalysts that address various synthetic challenges. Prominent examples from this dynamic field highlight remarkable enzymes for protecting‐group‐free amide formation and modification, control of pericyclic reactions, stereoselective hetero‐ and polycyclizations, atroposelective aryl couplings, site‐selective C−H activations, introduction of ring strain, and N−N bond formation. We also explore unusual functions of cytochrome P450 monooxygenases, radical SAM‐dependent enzymes, flavoproteins, and enzymes recruited from primary metabolism, which offer opportunities for synthetic biology, enzyme engineering, directed evolution, and catalyst design.
- Open Access
- 25 October 2023
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 63 (4) , e202309284
Novel Biocatalysts from Specialized Metabolism
Enzymes are increasingly recognized as valuable (bio)catalysts that complement existing synthetic methods. However, the range of biotransformations used in the laboratory is limited. Here we give an overview on the biosynthesis‐inspired discovery of novel biocatalysts that address various synthetic challenges. Prominent examples from this dynamic field highlight remarkable enzymes for protecting‐group‐free amide formation and modification, control of pericyclic reactions, stereoselective hetero‐ and polycyclizations, atroposelective aryl couplings, site‐selective C−H activations, introduction of ring strain, and N−N bond formation. We also explore unusual functions of cytochrome P450 monooxygenases, radical SAM‐dependent enzymes, flavoproteins, and enzymes recruited from primary metabolism, which offer opportunities for synthetic biology, enzyme engineering, directed evolution, and catalyst design.
- 25 October 2023
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 63 (4) , e202309284
Open AccessNovel Biocatalysts from Specialized Metabolism
Enzymes are increasingly recognized as valuable (bio)catalysts that complement existing synthetic methods. However, the range of biotransformations used in the laboratory is limited. Here we give an overview on the biosynthesis‐inspired discovery of novel biocatalysts that address various synthetic challenges. Prominent examples from this dynamic field highlight remarkable enzymes for protecting‐group‐free amide formation and modification, control of pericyclic reactions, stereoselective hetero‐ and polycyclizations, atroposelective aryl couplings, site‐selective C−H activations, introduction of ring strain, and N−N bond formation. We also explore unusual functions of cytochrome P450 monooxygenases, radical SAM‐dependent enzymes, flavoproteins, and enzymes recruited from primary metabolism, which offer opportunities for synthetic biology, enzyme engineering, directed evolution, and catalyst design.
- Open Access
- 24 October 2023
- Published by Wiley in ChemBioChem
- Vol. 24 (24) , e202300680
Analysing Megasynthetase Mutants at High Throughput Using Droplet Microfluidics**
Nonribosomal peptide synthetases (NRPSs) are giant enzymatic assembly lines that deliver many pharmaceutically valuable natural products, including antibiotics. As the search for new antibiotics motivates attempts to redesign nonribosomal metabolic pathways, more robust and rapid sorting and screening platforms are needed. Here, we establish a microfluidic platform that reliably detects production of the model nonribosomal peptide gramicidin S. The detection is based on calcein‐filled sensor liposomes yielding increased fluorescence upon permeabilization. From a library of NRPS mutants, the sorting platform enriches the gramicidin S producer 14.5‐fold, decreases internal stop codons 250‐fold, and generates enrichment factors correlating with enzyme activity. Screening for NRPS activity with a reliable non‐binary sensor will enable more sophisticated structure‐activity studies and new engineering applications in the future.
- 24 October 2023
- Published by Wiley in ChemBioChem
- Vol. 24 (24) , e202300680
Open AccessAnalysing Megasynthetase Mutants at High Throughput Using Droplet Microfluidics**
Nonribosomal peptide synthetases (NRPSs) are giant enzymatic assembly lines that deliver many pharmaceutically valuable natural products, including antibiotics. As the search for new antibiotics motivates attempts to redesign nonribosomal metabolic pathways, more robust and rapid sorting and screening platforms are needed. Here, we establish a microfluidic platform that reliably detects production of the model nonribosomal peptide gramicidin S. The detection is based on calcein‐filled sensor liposomes yielding increased fluorescence upon permeabilization. From a library of NRPS mutants, the sorting platform enriches the gramicidin S producer 14.5‐fold, decreases internal stop codons 250‐fold, and generates enrichment factors correlating with enzyme activity. Screening for NRPS activity with a reliable non‐binary sensor will enable more sophisticated structure‐activity studies and new engineering applications in the future.
- Open Access
- 25 July 2023
- Published by Royal Society of Chemistry (RSC) in RSC Chemical Biology
- Vol. 4 (9) , 692-697
Biosynthetic incorporation of fluorinated amino acids into the nonribosomal peptide gramicidin S
Fluorine is a key element in medicinal chemistry, as it can significantly enhance the pharmacological properties of drugs. In this study, we aimed to biosynthetically produce fluorinated analogues of the antimicrobial cyclic decapeptide gramicidin S (GS). However, our results show that the A-domain of the NRPS module GrsA rejects 4-fluorinated analogues of its native substrate Phe due to an interrupted T-shaped aromatic interaction in the binding pocket. We demonstrate that GrsA mutant W239S improves the incorporation of 4-fluorinated Phe into GS both in vitro and in vivo. Our findings provide new insights into the behavior of NRPSs towards fluorinated amino acids and strategies for the engineered biosynthesis of fluorinated peptides.
- 25 July 2023
- Published by Royal Society of Chemistry (RSC) in RSC Chemical Biology
- Vol. 4 (9) , 692-697
Open AccessBiosynthetic incorporation of fluorinated amino acids into the nonribosomal peptide gramicidin S
Fluorine is a key element in medicinal chemistry, as it can significantly enhance the pharmacological properties of drugs. In this study, we aimed to biosynthetically produce fluorinated analogues of the antimicrobial cyclic decapeptide gramicidin S (GS). However, our results show that the A-domain of the NRPS module GrsA rejects 4-fluorinated analogues of its native substrate Phe due to an interrupted T-shaped aromatic interaction in the binding pocket. We demonstrate that GrsA mutant W239S improves the incorporation of 4-fluorinated Phe into GS both in vitro and in vivo. Our findings provide new insights into the behavior of NRPSs towards fluorinated amino acids and strategies for the engineered biosynthesis of fluorinated peptides.
- Open Access
- 18 July 2023
- Published by Wiley in Angewandte Chemie
- Vol. 135 (35)
Gerichtete Evolution von Piperazinsäureeinbau durch eine Nichtribosomale Peptidsynthetase**
Das Engineering biosynthetischer Enzyme wird zunehmend eingesetzt, um strukturelle Analoga von Antibiotika zu synthetisieren. Von besonderem Interesse sind nichtribosomale Peptidsynthetasen (NRPS), die für die Produktion wichtiger antimikrobieller Peptide verantwortlich sind. Hier beschreiben wir, wie durch gerichtete Evolution einer Adenylierungsdomäne eines Pro‐spezifischen NRPS‐Moduls dessen Substratspezifität vollständig auf die Nicht‐Standard‐Aminosäure Piperazinsäure (Piz) geändert wurde, welche eine labile N−N‐Bindung enthält. Dieser Erfolg wurde durch UPLC‐MS/MS‐basiertes Screening kleiner, rational konzipierter Mutantenbibliotheken erzielt und kann vermutlich mit einer größeren Anzahl von Substraten und NRPS‐Modulen repliziert werden. Die evolvierte NRPS ist in der Lage, ein Piz‐beinhaltendes Gramicidin S‐Analogon zu produzieren. Damit geben wir der zu früh verworfenen Idee neuen Auftrieb, dass weithin zugängliche Methoden mit niedrigem Durchsatz die Spezifität von NRPS in einer biosynthetisch nützlichen Weise verändern können.
- 18 July 2023
- Published by Wiley in Angewandte Chemie
- Vol. 135 (35)
Open AccessGerichtete Evolution von Piperazinsäureeinbau durch eine Nichtribosomale Peptidsynthetase**
Das Engineering biosynthetischer Enzyme wird zunehmend eingesetzt, um strukturelle Analoga von Antibiotika zu synthetisieren. Von besonderem Interesse sind nichtribosomale Peptidsynthetasen (NRPS), die für die Produktion wichtiger antimikrobieller Peptide verantwortlich sind. Hier beschreiben wir, wie durch gerichtete Evolution einer Adenylierungsdomäne eines Pro‐spezifischen NRPS‐Moduls dessen Substratspezifität vollständig auf die Nicht‐Standard‐Aminosäure Piperazinsäure (Piz) geändert wurde, welche eine labile N−N‐Bindung enthält. Dieser Erfolg wurde durch UPLC‐MS/MS‐basiertes Screening kleiner, rational konzipierter Mutantenbibliotheken erzielt und kann vermutlich mit einer größeren Anzahl von Substraten und NRPS‐Modulen repliziert werden. Die evolvierte NRPS ist in der Lage, ein Piz‐beinhaltendes Gramicidin S‐Analogon zu produzieren. Damit geben wir der zu früh verworfenen Idee neuen Auftrieb, dass weithin zugängliche Methoden mit niedrigem Durchsatz die Spezifität von NRPS in einer biosynthetisch nützlichen Weise verändern können.